The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Arta Peptidion
Italy
B
1-10 Employees
-
Key takeaway
Arta Peptidion is a biotechnology company focused on the research and development of bioactive peptides and peptidomimetics, particularly for pharmaceutical applications. With a commitment to innovation, they aim to create first-in-class therapeutic peptides that address the evolving needs of the pharmaceutical and veterinary sectors.
Reference
Core business
Custom Designed Peptides and Bioactive Peptidomimetics | Arta Peptidion
Arta Peptidion is a private biotechnology company for the research and the development of Peptides and Bioactive Peptidomimetics. Download our Brochure.
NANOPEP
Silvi, Italy
B
11-50 Employees
2005
Key takeaway
NANOPEP is a biotechnological company that specializes in developing therapeutic products based on peptide bioregulation technology, including dietary supplements that enhance thyroid function through short peptides. Their offerings highlight the potential of peptides in advanced therapeutic applications.
Reference
Product
Buy peptide products in biotechnological company Nanopep: order premium quality peptide products with worldwide delivery
Nanopep company offers unique products based on peptides. Here you can buy epitide, epitalon spray, vilon, epitalon, and other peptide products.
IRBM SPA
Pomezia, Italy
B
101-250 Employees
2009
Key takeaway
IRBM highlights its expertise in drug discovery and emphasizes the unique position of peptide therapeutics, which are distinct from both small molecules and proteins. This focus on innovative and effective therapeutics aligns with the company's commitment to improving patients' quality of life.
Reference
Service
Peptide Drugs - IRBM
Peptides represent a unique class of pharmaceutical compounds, molecularly poised between small molecules and proteins, yet biochemically and therapeutically distinct from both.
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Tes Pharma srl
Italy
B
1-10 Employees
-
Key takeaway
Tes Pharma is a biotech company that specializes in developing innovative drug candidates, particularly in the fields of oncology and metabolic diseases. Their focus on translating scientific research into novel therapeutic opportunities suggests a commitment to advancing peptide therapeutics.
Reference
Core business
About Us | Tes Pharma
Enthera
Milan, Italy
B
1-10 Employees
2016
Key takeaway
The company is developing first-in-class biologics, including selective inhibitors, to treat challenging autoimmune diseases. Their lead program, Ent001, has the potential to preserve pancreatic beta cells in type 1 diabetes and restore intestinal structure in inflammatory bowel disease, addressing significant unmet medical needs.
Reference
Core business
Enthera – First-in-class therapeutics for auto-immune disorders
PRECISION BIOTHERAPEUTICS SRL IN BREVE PRE BIOT SRL
Italy
B
1-10 Employees
2019
Key takeaway
Precision BioTherapeutics specializes in biotech research, focusing on chemical and pharmaceutical products, including pre-biotics and probiotics.
Reference
Core business
Precision Bio-Therapeutics - Biotech Research - PreBioT
Precision Bio-Therapeuthics is a Biotech platform research for chemical and pharmaceutical products (pre-biotics, probiotics,post-biotics).
Reithera Srl
Rome, Italy
B
101-250 Employees
2005
Key takeaway
ReiThera is a biotech company specializing in the development and production of genetic vaccines and biopharmaceutical products for advanced therapies, particularly targeting major infectious diseases such as hepatitis C, malaria, and HIV. Their expertise in gene delivery technologies and GMP manufacturing positions them as a key player in the field of peptide therapeutics and related research.
Reference
Core business
An ideal partner for your translational research • Reithera
We develop and produce biopharmaceutical products for advanced therapies, in order to treat several serious or life-threatening diseases.
Thena Biotech
Italy
B
1-10 Employees
-
Key takeaway
Thena Biotech is focused on developing innovative biotherapeutics that utilize engineered human ferritins for targeted delivery of therapeutic agents to cancer sites, significantly reducing non-specific side effects. Their portfolio aims to address unmet medical needs in cancer treatment through novel nanomedicine platforms.
Reference
Core business
Our Project
MimeTech
Florence, Italy
B
- Employees
2004
Key takeaway
MimeTech Srl specializes in the development of synthetic neurotrophin mimetics, which are relevant to peptide therapeutics. The company was founded by two scientists from the University of Firenze, emphasizing its strong academic and research background.
Reference
Core business
MimeTech – Synthetic Neurotrophin Mimetics
Dario Castagno and RASNA Extra Virgin Olive Oil
Italy
B
1-10 Employees
-
Key takeaway
Rasna Therapeutics is dedicated to developing therapeutics for acute myeloid leukemia (AML) and other leukemias, highlighting their focus on addressing significant unmet medical needs in this area.
Reference
Core business
Welcome | Rasna Therapeutics
Technologies which have been searched by others and may be interesting for you:
When exploring the Peptide Therapeutics industry in Italy, several key considerations come into play. Regulatory frameworks are crucial, as the European Medicines Agency (EMA) oversees the approval and marketing of peptide-based drugs, ensuring compliance with stringent safety and efficacy standards. Additionally, Italy has specific national regulations that may impact the development and commercialization of peptide therapeutics, including guidelines on clinical trials and market access. The competitive landscape is characterized by a mix of established pharmaceutical companies and innovative biotech startups, creating a dynamic environment rich in collaboration and research opportunities. Challenges such as high development costs and complex manufacturing processes must be navigated, alongside the need for robust intellectual property protection to safeguard innovations. Opportunities exist in addressing unmet medical needs, particularly in areas like oncology and metabolic disorders, where peptide therapeutics have shown promise. The global market relevance is significant, with Italy being part of a broader European market that is increasingly investing in biopharmaceutical research and development. Environmental concerns related to the production of peptides, such as waste management and sustainability practices, are also gaining importance, prompting companies to adopt greener technologies. Overall, thorough market research and an understanding of these factors are essential for anyone looking to enter or invest in the peptide therapeutics sector in Italy.
Some interesting numbers and facts about your company results for Peptide Therapeutics
Country with most fitting companies | Italy |
Amount of fitting manufacturers | 176 |
Amount of suitable service providers | 119 |
Average amount of employees | 1-10 |
Oldest suiting company | 2004 |
Youngest suiting company | 2019 |
Some interesting questions that has been asked about the results you have just received for Peptide Therapeutics
What are related technologies to Peptide Therapeutics?
Based on our calculations related technologies to Peptide Therapeutics are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Which industries are mostly working on Peptide Therapeutics?
The most represented industries which are working in Peptide Therapeutics are Biotechnology, Other, Pharmaceuticals, Medical, Healthcare
How does ensun find these Peptide Therapeutics Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.